8EY2 image
Deposition Date 2022-10-26
Release Date 2022-12-07
Last Version Date 2024-05-01
Entry Detail
PDB ID:
8EY2
Keywords:
Title:
Cryo-EM structure of SARS-CoV-2 Main protease C145S in complex with N-terminal peptide
Biological Source:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.50 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:3C-like proteinase
Gene (Uniprot):rep
Chain IDs:A, B (auth: C), C (auth: D), D (auth: B)
Chain Length:314
Number of Molecules:4
Biological Source:Severe acute respiratory syndrome coronavirus 2
Primary Citation
An in-solution snapshot of SARS-COV-2 main protease maturation process and inhibition.
Nat Commun 14 1545 1545 (2023)
PMID: 36941262 DOI: 10.1038/s41467-023-37035-5

Abstact

The main protease from SARS-CoV-2 (Mpro) is responsible for cleavage of the viral polyprotein. Mpro self-processing is called maturation, and it is crucial for enzyme dimerization and activity. Here we use C145S Mpro to study the structure and dynamics of N-terminal cleavage in solution. Native mass spectroscopy analysis shows that mixed oligomeric states are composed of cleaved and uncleaved particles, indicating that N-terminal processing is not critical for dimerization. A 3.5 Å cryo-EM structure provides details of Mpro N-terminal cleavage outside the constrains of crystal environment. We show that different classes of inhibitors shift the balance between oligomeric states. While non-covalent inhibitor MAT-POS-e194df51-1 prevents dimerization, the covalent inhibitor nirmatrelvir induces the conversion of monomers into dimers, even with intact N-termini. Our data indicates that the Mpro dimerization is triggered by induced fit due to covalent linkage during substrate processing rather than the N-terminal processing.

Legend

Protein

Chemical

Disease

Primary Citation of related structures